The Mechanism and Function of Glia in Parkinson's Disease
- PMID: 35722618
- PMCID: PMC9205200
- DOI: 10.3389/fncel.2022.903469
The Mechanism and Function of Glia in Parkinson's Disease
Abstract
Parkinson's disease (PD) is a neurodegenerative disease that primarily affects elderly people. The mechanism on onset and progression of PD is unknown. Currently, there are no effective treatment strategies for PD. PD is thought to be the loss of midbrain dopaminergic neurons, but it has recently been discovered that glia also affects brain tissue homeostasis, defense, and repair in PD. The neurodegenerative process is linked to both losses of glial supportive-defensive functions and toxic gain of glial functions. In this article, we reviewed the roles of microglia, astrocytes, and oligodendrocytes in the development of PD, as well as the potential use of glia-related medications in PD treatment.
Keywords: Parkinson's disease; alpha-synuclein; astrocytes; microglia; oligodendrocytes.
Copyright © 2022 Zhang, Zhang, Nisa Awan and Bai.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications.Prog Brain Res. 2020;252:131-168. doi: 10.1016/bs.pbr.2020.02.004. Epub 2020 Mar 21. Prog Brain Res. 2020. PMID: 32247363 Review.
-
Glial cells improve Parkinson's disease by modulating neuronal function and regulating neuronal ferroptosis.Front Cell Dev Biol. 2025 Jan 3;12:1510897. doi: 10.3389/fcell.2024.1510897. eCollection 2024. Front Cell Dev Biol. 2025. PMID: 39830208 Free PMC article. Review.
-
Glial reactions in Parkinson's disease.Mov Disord. 2008 Mar 15;23(4):474-83. doi: 10.1002/mds.21751. Mov Disord. 2008. PMID: 18044695 Review.
-
NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.Int Immunopharmacol. 2020 Jun;83:106441. doi: 10.1016/j.intimp.2020.106441. Epub 2020 Apr 4. Int Immunopharmacol. 2020. PMID: 32259702 Free PMC article.
-
Astrocytes, Microglia, and Parkinson's Disease.Exp Neurobiol. 2018 Apr;27(2):77-87. doi: 10.5607/en.2018.27.2.77. Epub 2018 Apr 24. Exp Neurobiol. 2018. PMID: 29731673 Free PMC article. Review.
Cited by
-
Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson's Disease.Int J Mol Sci. 2024 Jan 5;25(2):694. doi: 10.3390/ijms25020694. Int J Mol Sci. 2024. PMID: 38255772 Free PMC article.
-
Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.Int J Mol Sci. 2023 Jun 9;24(12):9942. doi: 10.3390/ijms24129942. Int J Mol Sci. 2023. PMID: 37373089 Free PMC article.
-
Neuroprotective effects of taurine in a rodent model of parkinson's disease involve modulating astrocyte-mediated inflammation.Arch Pharm Res. 2025 Aug;48(7-8):814-829. doi: 10.1007/s12272-025-01563-z. Epub 2025 Aug 2. Arch Pharm Res. 2025. PMID: 40751776
-
The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases.Front Cell Neurosci. 2023 Sep 1;17:1233762. doi: 10.3389/fncel.2023.1233762. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37720543 Free PMC article. Review.
-
Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson's Disease?Biomolecules. 2023 Jan 15;13(1):178. doi: 10.3390/biom13010178. Biomolecules. 2023. PMID: 36671564 Free PMC article. Review.
References
-
- Bido S., Muggeo S., Massimino L., Marzi M. J., Giannelli S. G., Melacini E., et al. . (2021). Microglia-specific overexpression of alpha-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat. Commun. 12:7359. 10.1038/s41467-021-27737-z - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources